Acumen Research and Consulting Atrial Fibrillation Drugs Market is Anticipated to | Page 2

chronic conditions such as auric fibrillation, diabetes, high blood pressure etc. Moreover, the increase in cardiovascular prevalence in the United States, in particular, will boost the growth of the market for atrial fibrillation in the coming years. One of the major impending growth factors is the side effects linked to the regular intake of atrial fibrillation drugs. Side effects such as excessive bleeding, fatigue, etc. are likely to impair the growth of the market. In addition, a lack of awareness of recent pharmaceutical therapies is a further obstacle to growth. Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request- sample/1347 Industry Insights The market for auricular fibrillation anticoagulants was estimated at approximately US$ 11.5 trillion in 2018. Anticoagulants have been introduced in order to reduce atrial fibrillation in people with stroke. Anti-platelet or anticoagulant therapy based on the age of the patient and the presence of other risk factors should be considered in patients with atrial fibrillation. A substantial increase in the incidence of strokes associated with auric fibrillation has increased demand for anticoagulants in recent years and increased the growth of the market for atrial fibrillations. Would like to place an order or any question, please feel free to contact at [email protected] | [phone]